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Retinoie aeid induees expression of PA-FABP
(psoriasis-assoeiated fatty aeid-binding
protein) gene in human skin in vivo but not in
eultured skin eells
Gr0nh0j Larseti F, Voorhecs .1.1, Aslmm A. Rclitioic acid induces ex-
pfessioti of PA-FABP (psoriasis-associated fatly acid-bitiding pt'oteiti) get:e
it! hutnati skin in vivo but tiot iti cuhufcd skin cells.
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Abstract: PA-FABP (psoriasis-associated fatty acid-bitiding protein) is a
ticw tTtember of a group of low-tnolecular-weight proteins that are highly
up-regulated in psoriatic skin and that share similarity to fatty aeid-bind-
itig proteins. In this study we detnonstrate that PA-FABP transcripts are
expressed iti human skin in vivo atid that topical applicatioti of O.OS'Vti
retinoie aeid (RA) creatn results in a rapid induetion of PA-FABP tran-
seripts following treattnetit for 16 hours and persists at increasitig levels
al'tcr 48 and 96 h of RA treatment. The PA-FABP mRNA response to RA
was reduced by approxitnately 5O'>̂> when patients coneurrently were
treated with RA atid 0.025% clobetasol propionate (CLO) for 48 atid 96 h,
whereas treattnetit with CLO alone resulted in PA-FABP tratiscripl levels
tiot sigtiifteatitly different frotn vehicle-treated skiti. When eotnparing the
elTeets of a well-knowti irritatit, sodiutn lauryl sulfate (SLS), to those of
RA and its vehicle, 0.05% RA creatn but not 2% SLS iti RA vehicle caused
PA-FABP mRNA induction after 16 h. SLS treattnent of humati skin for
96 h eaused a slight increase in PA-FABP transeripts, but tnarkedly less
than that observed in tespotise to RA treattnent. Incubation of eultured
liumati keratinoeytes or skin fibroblasts with RA for up to 48 h did not
signifteantly induee PA-FABP transeripts. Exptession of PA-FABP tness-
age in keratinoeytes was observed to be itiduced by ealciutn and fetal ealf
serutn (FCS), while tetra-decatioyl phorbol acetate (TPA) eaused little or
no induction. Taken together, the tnarked inducibility of the PA-FABP
gene is compatible with the possibility that this gene tnight be itnportant
in RA-mediated regulation of human skin growth and differentiation.
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Introduction
The fatty acid-binding proteins (FABPs) belong to
a tnultigene family of low molecular weight cyto-
plasmic binding proteins («14-15 kDa) that bind
fatty acids, and are abundantly expressed in tissues
specialized in the synthesis, transport, storage and
utilization of fatty acids. Their putative tnain
physiological significance is the assurance that
long-chain fatty acids and derivatives, either in
Iransil through membranes or present in intra-
cellular compartmetits, are largely cornplexed to
proteins (1). Also, since recent data indicate the
involvetnent of fatty acids and fatty aeid deriva-
tives (e.g., eicosanoids) in cellular growth and dif-
ferentiation and signal transduction pathways,
their respective binding proteins may also function
in these complex processes (2, 3).
The epidermis is a specialized tissue oflipid me-
tabolism, but cannot synthezise sotne of the fatty
acids (i.e., linoleic acid, arachidonic acid) that are
itnportant for epidermal growth and barrier func-
tions (4). Thus, fatty acid transport in the skin and
its metabolistn may be facilitated by FABPs. In
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fraclionaled non-cullurcd psorialic keralinoeyles
Ihere is evidence of an allered laity acid Iransporl
and metabolism which is in hne wilh the dramatic
up-regulalion of a group of FABPs including psor-
iasin, calgranulin A and B. and cystatin A (5. 6).
Recently, Madsen et al. (7) identified a new mem-
ber of this group that is highly up-regulated at the
message and protein levels in non-cultured psori-
atic keratinocytes and termed it PA-FABP (pso-
riasis-associated fatty acid-binding protein). How-
ever, nothing is known about PA-FABP gene ex-
pression and regulation in human skin. The main
purpose of the present study was to examine the
regulation of PA-FABP gene expression in human
skin /'// vivo as well as in cultured skin cells. Since
topical retinoic acid can cause an erythemalous re-
action clinically similar to irritant dermatitis (8-
10). an important issue is the extent to which alter-
ations induced by RA are caused by its irritant
properties or by more physiologically relevant
mechanisms. Therefore, we have also examined the
effects of the irritant sodium lauryl sulfate (SLS)
as well as the anti-inflammatory compound clobet-
asol propionate (CLO) on expression of PA-FABP
Material and methods
Potymera.se ehaitt reaetioit (PCR) and cDNA
cloning
PCR was carried out in an automated Perkin-Elm-
er Cetus thermocycler using 1 |.ig of total RNA
extracted from keratomc biopsies of psoriatic skin.
RNA was reverse transcribed into a complement-
ary DNA using reverse transcriptase (2.5 U) and
oligo d(T)16 as primers (2.5 |.iM). at 42°C for 25
min, in a total volume of 20 pi buffer (5 mM
IVlgCU, IX reaction buffer as supplied by the
manufacturer, 1 mM dXTP 1 mM RNase inhibi-
tor) overlaid with 70 \i\ of mineral oil (Gene Amp.
RNA Kit, Perkin Elmer Cetus. CT. USA). Thirty-
five cycles of PCR amplification (95°C. 1 min.
5()°C, 1 min, 72°C. 1 min) were performed in 100
|.il using Ampli Taq DNA poiymerase (2.5 U). 2.6
mM MgCU. IXreaction buffer, and 0.15 |.iM (final
concentration) of each primer as suggested by the
manufacturer. The oligonucleotide primers were
synthesized by the University of Michigan DNA
core facility and based upon a previously pub-
lished cDNA sequence (7). Fach primer had 25 nu-
eleotides hybridizing to its template and at its 5'-
end. a restriction site and 6 additional nueleotides
that facilitate complete digestion with the restric-
tion enzymes. Fco RI and Bam HI sites were con-
tained in the forward and reverse primers, respec-
tively The primers were designed so as to amplify
the coding region and were as follows:




The length of the amplified DNA was determined
on a 1.5% agarose gel. The amplified 633-bp region
of PA-FABP was isolated from the gel. ethanol
precipitated and subcloned into plasmid pSG5
(Stratagene. La Jolla, CA, USA).
Skitt biopsies
For in vivo treatment. 0.05'Mi retinoie aeid cream,
its vehicle (Ortho Pharmaceuticals. Raritan. N.I.
USA) or 0.025% clobetasol propionate (CLO)
ointment (Glaxo Dermatology. NC. USA) was ap-
plied onee as 3x9 cm patches to buttock skin and
maintained under plastic wrap for 24. 48. or 96 h
prior to biopsy. When patients concurrently were
treated with RA and CLO equal amounts of 0.1%
RA and 0.05% CLO (approximately 250 mg of
each) were mixed and applied to the skin. Subjects
were also treated I or 16 or 96 h under occlusion
with 2'Ki SLS. SLS was obtained from F.I. Dupont
De Nemours & Company (Wilmington. DF. USA)
and eompounded at 1% in RA vehicle cream. After
obtaining written informed consent, keratome
biopsies consisting primarily of epidermis (11)
were procured from the treated areas using \%
plain lidocaine as a local anesthetic. Epidermal
keratomes were immediately frozen in liquid nitro-
gen and stored at -70°C until use. All subjects
provided written, informed consent and all pro-
cedures were performed under approval of the
University of Michigan Medieal Center Insti-
tutional Review Board.
Cell ettltttre
Human keratinoeytes were purchased from
Clonetics and expanded to about 5O'Xi confluency
in 150-mm tissue culture dishes in a low Ca^^
(0.15 mM). serum-free keratinocytc growth me-
dium (KGM) eontaining epidermal growth factor
(EGF") (0.1 ng/ml). insulin (5 |.ig/ml). hydrocorti-
sone (0.5 |.ig/ml). bovine pituitary extract, genta-
micin (50 ).ig/mi). and amphotericin-B (50 ng/ml)
(Clonetics, San Diego, CA. USA). The effecH of
glueocorticoid was examined after the medium was
replaced with hydrocorlisone-free KGM medium
48 h prior to treatment. Cells were treated up to
48 h with 1 |.iM RA or calcium (2 mM) or with
FCS (10%) or TPA (20 nM).
Human dermal fibroblasts were also used in this
study. They were prepared IVom punch biopsies of
buttoek skin (12) and propagated in Dulbecco's
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modified Eagle's medium eontaining l()'^ felal ealf
serum (FCS), 100 U/ml of penieilihi, and 100 |.ig/
ml of streplomyein. Cells were then grown lo eon-
llueney in 150-mm tissue eullure dishes (Corning
Glass Co., Corning, NY, USA) and treated for up
lo 48 h.
Cells were maintained in a humidified ineubator
al 37°C wilh 5'Mi CO2/95% air. When eells were
treated wilh RA, Ihey were proleeled from light
during lhe ineubation period. Experiments were
eondueled on eells in the third through sixth
passage.
Northern analvsis of ittRNA
RNA was isolated from eultured human skin
fibroblasts, keratinoeytes or frozen keralome
biopsies by guanidinium isothioeyanate lysis and
ullraeentrifugation as previously deseribed (13).
Brielly, RNA eoneentrations were determined by
absorbanee at 260 nm and equal quantities of
lolal RNA were eleetrophoretieally separated in
1% Ibrmaldehyde-agarose gels containing 0.5 |,ig/
ml ethidium bromide. Twenty mierograms total
RNA was transferred to derivatized nylon mem-
branes (Zela-Probe, Bio-Rad, Richmond, CA,
USA). Fillers were baked 2 h at 80°C /// vaetto..
then prehybridized for 2-4 h at 42°C in 5O'M) form-
amide, 5XSSC (1XSSC=15O mM NaCl, 15 mM
sodium citrate), 50 mM sodium phosphate, pH
7.0, lxDenhardt's solution, 250 |.ig/ml yeast
IRNA, 100 |.ig/ml sonicated herring sperm DNA,
and \"/i) SDS. Hybridization was earried out lor
18 h at 42°C in the same buffer. Blots were se-
quentially hybridized against ""-P-labeled PA-
FABP and eyelophilin (14) probes prepared by
random priming. Quanliiation of mRNA levels
was performed using a phosphorimager (Molecu-
lar Dynamics, Sunnyvale, CA, USA), and PA-
FABP message levels were normalized to eyelophi-
lin. Filters were washed onee in 0.2XSSC, 0.1%
SDS at room temperature, then Iwiee for 15 min
in 0.2XSSC, 0.1% SDS at 56°C and finally onee
for 15 min in O.lxSSC, 0.1% SDS also al 56°C.
An adult Multiple Tissue Northern Blot was pur-
chased from Clonleeh Lab., Inc. and eontained 2
|.ig in eaeh lane of highly pure poly (A)'RNA
from 8 dilTerent tissues. Auloradiography was per-
formed using intensifying screens at -70°C.
Slalislics
For eaeh duralion of lime (i.e. 16, 24, 48, and 96
h) the -fold induelion was compared to unity by a
one-sample t-tesl. All p-values are Iwo-tailecl.
Results
E.xpressiott of PA-EABP mRNA in httman skin in
vivo
PA-FABP transeripts were deteetable in untreated
skin (data nol shown) as well as skin treated with
vehiele (Fig. 1). As shown in Fig. 1, PA-FABP
mRNA was markedly and signifieantly increased
by RA treatment compared to vehicle-treated skin
at all time points studied (24, 48, and 96 h). Induc-
tion was observed as early as 16 h after topical RA
treatment (mean 2.0-fold±0.23 SEM, p=0.006,
n = 7) (data not shown) wilh increasing values fol-
lowing treatment for 24 h (mean 2.8-fold±0.34
SEM, p=0.()()6), 48 h (mean 8.2-fold±2.5 SEM,
p=0.04), and 96 h (mean 17.3-fold±5.5 SEM, p=
0.03). However, a considerable inter-individual
variation in -fold induetion existed both at 48
(range 3 to 18) and 96 h (range 5 to 34). At these
time points the induetion of PA-FABP mRNA by
RA was redueed by approximately 5()%i when pa-
tients concurrently were treated with RA and
CLO. Treatment wilh CLO alone resulted in PA-
FABP transcript levels not significantly dilTerent
from vehiele-treated skin.
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TIME OF TREATMENT (HOURS)
I'lgttre I. tt) Incluclion of PA-H'AliP mRNA in human skin liy
topically applied iclinoic acid cream (RA). Eacli volunteer was
treated with ().()5'^ RA, its vehicle, 0.0257n clobetasol propi-
onate ointment (CLO), or RA and CLO in combination undei'
occlusion for the times indicated prior to biopsy. /; is the nmn-
ber of RA, CLO or RA/CLO treated patients obtained at each
time point, hj autoradiographic bands from two representative
experiments following treatment for 48 and 96 h.
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usitig a 0-9 scale. 0 rcprcsctiting absetil, atid 9
maxitnal erylhema (10). Hovvevcf, ihcfc was tio
coffelatioti bctweeti dcgfce of erythema and -fold
induction by RA.
Efject of .sodittnt lattrvl sulfttc ott PA-EABP
e.xpressiott itt httmatt skitt in vivo
The above data clearly detnonstrate that PA-FABP
expression is increased in skin treated with topical
RA. To determine whether this response was speci-
fic to RA, biopsies were obtaitied frotn subjects
treated with the irritant sodiutn lauryl sulfate
(SLS) prepared in retinoie aeid vehiele for 16 or 96
h under occlusion. Both 2'X. SDS and 0.05"/, RA
produced a marked inerease in erythetna relative
to vehiele after 96 h, which was eotnparable be-
tween the two agents. Little or no erythetna was
ob.served in response to vehicle after 96 h, nor to
any of the treattnents after 16 h. In 7 patients
treated with SLS or RA cream for 16 h. PA-FABP
transeripts were not signifieantly induced eotn-
pared to vehicle following SLS treattnent (tnean
0.96-fold ±0.06, p=0,54), while as tnentiotied
above RA treattnent resulted in a signifieant induc-
tion. Also, the inditetion of PA-FABP mRNA by
SLS after treatment for 96 h was tnarkedly less
than that obtained in response to RA (Fig. 2).
E.xpression of PA-EABP itt htimatt kercttittocytcs
(tnd fibroblasts
Because RA itiduced PA-FABP tnRNA //;
was of interest to determine whether an induction
also occurred in cultured human keratinoeytes.
Subconlluent cultures of keratinocytes were har-













Figttre .1. Iiultiction of PA-I'ABP iiiRNA t\\ calcium (C A ' ) (2
iiiM) and retinoic acid (RA) (1 pM) in normal adnlt human
keratinocytcs. When cells were 50"„ contUicnl. tlie>' were either
maintained in hydrocortisone-containing RCiM (Clonetics)
growth media or the media were I'cplaccd with hydrocortisonc-
IVce KGM media 4iS li prior to Ca ' ' or RA ircatmcnl.
levels were detertnined. In untreated keratinoeytes,
PA-FABP mRNA was at a low but deteetable level.
Treattnent of keratinoeytes by RA for 24 or 48 h
did not induee PA-FABP tnRNA when eells were
grown in the presetice or absetiee of hydroeortisone
(Fig. 3). When grown in the presenee of hydrocor-
tisone, tnarkedly lower tratiscript levels were ob-
served in both utistimulated (control) and stitnu-
lated eells. Treattnent with caleium for 48 h re-
sulted it! an approxitnately 2-fold induetion of PA-
FABP transcripts. In a separate experiment, in-
eubation of keratinocytes with FCS (1 ()"/(!) for 48 h
also induced PA-FABP gene expressioti (== 3-fold),
while TPA (20 tiM) had little or no indueible elTeet
(data not shown). Induction of PA-FABP ex-
pression by RA was also detertnined in fibroblasts.
hi these cells, transcripts were undeteetable both
in utitreated eells and in eells after treattnent with

















I'igttre :. Induction ofPA-PABP mRNA in htiman skin by top-
ically applied sodium lauryl suH'ate (.SLS) or retinoie acid cream
(RA). Four individuals were treated lor 96 h under occlusion
with vehicle (V). 2% SLS, or 0.{)5"A: RA. Total RNA (20 jig per
lane) was successively lilter hybridized with ''P-labeled cDNA
probes for PA-FABP and eyelophilin.
Presettee of PA-E.iBP tttRNA itt (tdttlt hutttittt
tissties
To detertnine the tissue distribution of PA-FABP
gene expression, poIy(A)' RNA frotn various adult
hutnan tissues was analyzed (Fig. 4). Ofthe tissues
exatnined, heart and plaeenta had a high level of
PA-FABP tnRNA, while brain, lung, skeletal
tnusele and panereas had tnoderate levels. In li\er
and kidney tissue levels of PA-FABP transcripts
vvere not detectable.
Discussion
Low-molecular-weight FABPs are abundant (i.e.,
1 1% of eytosolie protein) in tissues that are aetive
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h'li^iire 4. i;.\pression of basal PA-I-ABP mRNA levels in vari-
ous adult human tissues.
in lally acid synlhesis. Iransporl, storage, or ulil-
izalion (15, 16). Whereas the lipid tnelabolie aeliv-
ity tnight predict the presence of cytosolic FABPs
in epidertnis, available data are conllicting. Thus,
Schurer et al. (17) found that cytosol frotn epider-
tnis /// vivo atid //; vitro showed no fatty acid bitid-
ing activity within the molecular weight range (12
14 kDa) of these conventional FABPs. However,
Siegenthaler et al. (18) characterized an E-FABP
(15 kDa) in human epidertnal cells that binds oleic
acid with high affitiity but does tiot bind all-trans-,
13-cis- and 9-cis-retinoic acid nor all-trans-retinol.
They also showed that expression levels of E-FABP
were low iti nortnal epidermis, higher in hutnan
cultured keratinocytes and still higher in psoriasis.
Recently, Madsen et al. (7) also identified a protein
(PA-FABP) with homology to other tnetnbers of
the FABP fatnily, that was highly up-regulated in
psoriatic skin. Whether PA-FABP and E-FABP
are the satne or dilTerent proteins retnains to be
investigated.
We have previously cloned and investigated the
regulation of a hutnan retinoic acid binding pro-
tein (CRABP-II), which is a tnetnber of the hydro-
phobic ligand binding fatnily of proteins that in-
cludes FABPs and CRBPs (13, 19, 20). It has been
shown that CRABP-ll is highly indueible by RA
and is also overexpressed in psoriasis (13, 19 21).
For this reason we detertnined whether PA-FABP
also was regulated by RA. Interestingly, PA-FABP
tnRNA was induced following RA treattnent for
16 h, whereas no induction was observed, cotn-
pared to vehicle-treated skin, following SLS treat-
tnent for the satne period of titne. Despite the in-
duction of tnarked erythema by both SLS and RA
after treattnent for 96 h, the induction of PA-
FABP tnRNA by SLS was tnarkedly less than that
obtained in response to RA (Fig. 2). It has pre-
viously been showti that SLS and RA elicit a sitni-
iar clinical and histologic response following treat-
tnent for 96 h (9). Also, a titne-course cotnparison
detnonstrated that RA induced epidertnal thicken-
itig, stratutn eorneutn cotnpitctioti, spongiosis, and
tnitotic figures tnore rapidly than did SLS (22).
Taketi together, these fmdings indicate differing
tneehanistns of aetions of the two agents, and that
the PA-FABP tnRNA induetion by RA in hutnan
skin itt vivo cannot be accounted for by irritant
effects. A sitnilar effect of RA and SLS on
CRABP-II tnRNA levels in hutnan skin //; vivo has
also been demonstrated (10).
Giucocorticoids are effective for the treattnent
of various inflatnmatory skin diseases including
psoriasis. Retinoids exert an opposite effect cotn-
pared to glueocortieoids and cause hyperplasia of
the skin when applied topically (9, 22). It has been
shown that retinoids can reverse glueocorticoid-in-
duced atrophy in hutnans and tnice, while the anti-
inllatntnatory property of giucocorticoids is not
affected (23, 24). Jt was therefore of interest to in-
vestigate the effeels of glucoeorticoids on PA-
FABP expression. We found that CLO opposed
the effect of RA-induced PA-FABP expression in
hutnan skin /// vivo (Fig. 1). Whether this effect of
CLO on PA-FABP expression is due to a direct
down-regulation of the gene by the glucocorticoid
receptor or is a secondary effect retnaitis to be iti-
vestigated. It was, however, clear frotn the //; vitro
experitnent that PA-FABP transcripts were tnark-
edly lower in both unstitnulated and stitnulated
keratinocytes when grown in the presence of
hydrocortisone, which favors the possibility thai
giucocorticoids directly dowti-regulate the PA-
FABP gene (Fig. 3).
Exposure of keratinizing cells to retitioids has
been shown to inhibit the normal sequence of
keratin expression (25) and eornified envelope for-
mation (26). The extent of keratinocyte differen-
tiation can be enhanced under subtnerged con-
ditiotis, when the keratinocytes are citltured in the
presence of delipidized serutn to reduce the level of
RA (25). Furthertnore, addition of RA at
tiiicromolar eoncenttations to subtnetged eultures
grown in RA-depleted medium induces marked
changes in lipid synthesis atid lipid compositioti
with a deereased cholesterol sulfate produetion
(27) and leads to a eotnplete suppression of acyl-
ceratnide and lanosterol synlhesis (28). Our find-
ings that treattnent of subconfluent cultures of
keratitiocytes with RA for up to 48 h showed un-
altered or a tendency towards decreased PA-F"ABP
mRNA levels as eotnpared with basic levels tnight
thus possibly reflect an altered lipid tnelabolistn
(Fig. 3). In contrast to RA, when growti at physio-
logical calciutn concentrations, keratinocyles dis-
play a tnarkedly higher capacity to differetitiate.
Also, both involucrin content atid transglutatnin-
ase activity, two key delertninants of eornified en-
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velope during terminal differentiation, are aeeeler-
ated and begin to occur prior to confluence when
the extracellular calcium concentrations are raised
to physiological levels (29). PA-FABP mRNA was
fouud to respond to both external calcium (2 mM)
(Fig. 3) and FCS (10%) (data not shown) whieh
favors the concept that the stratified structure of
the epidermis and/or the presence of dermis is an
important determinant of PA-FABP regulation /'/;
vivo. Taken together, our findings are in accord-
ance to those of Madsen et al. (7) who found that,
under conditions that promoted incomplete ter-
minal differentiation (10% FCS), PA-FABP and a
few other proteins were strongly up-regulated.
Although the FABPs have functional similar-
ities, their amino acid sequences are unique for
each tissue type; but across species the FABP of a
specific tissue has a highly conserved amino acid
sequence. The tissues containing the most abun-
dant quantities of the FABPs are found in liver
(3'^ of cytosol protein), intestine (1 -2'Mi of cytosol
protein), and heart musele (5% of cytosol protein)
(30). Using a PAGE-autoradioblotting technique,
Siegenthaler et al. (18) demonstrated that liver-, in-
testine-, and heart- when compared to B-FABP
showed distinct mobilities, suggesting that the pri-
mary structure of F-FABP may be different in
these tissue. The study also showed that E-FABP
was detectable in adipose tissues. The present
study reveals that PA-FABP mRNA expression is
not restricted to epidermal cells sinee high or mod-
erate message levels were deteeted in heart, pla-
centa, brain, lung, skeletal muscle and pancreas.
In eonclusion, the main findings of the present
study show that PA-FABP is regulated by RA in
human skin in vivo but not in eultured keratino-
eytes or skin fibroblasts. We also demonstrate that
PA-FABP mRNA induction by RA in human skin
cannot be explained by its "irritant" properties
sinee PA-FABP mRNA induction after 96 h is
markedly less following topical application of the
irritant SLS than that obtained in response to top-
ical RA treatment. Allhough PA-FABP was
named such because it is highly up-regulated in
psoriatic keratinocytes the present study shows
that it is simply an RA-regulated FABP found
both in skin and several other tissues.
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